ArticleCureus2020
Reactive Arthritis After COVID-19 Infection.
Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 39 citations in OpenAlex.
- COVID-associated arthritis after severe and non-severe COVID-19: A systematic review.Immunity, inflammation and disease · 2023Pooled it
- Reactive arthritis following COVID-19 current evidence, diagnosis, and management strategies.Journal of orthopaedic surgery and research · 2023Pooled it
- COVID-19 with Suspected Secondary Pyogenic Arthritis of the Hip: A Case Report and Literature Review.Journal of orthopaedic case reports · 2024Article
- Long-term rheumatoid manifestations as a consequence of COVID-19 and/or vaccination: A case report after a 2-year follow-up.Heliyon · 2024Article
- Reactive arthritis following COVID-19: clinical case presentation and literature review.Rheumatology international · 2024Review
- Investigation of recurrence of joint symptoms after COVID-19 in patients with rheumatoid arthritis: Cross-sectional study.Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences · 2024Article
- [Clinical relationship between reactive arthritis and SARS-CoV-2 infection: A scoping review].Revista colombiana de reumatologia · 2023Review
- Reactive arthritis following COVID-19: cause for concern.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023Article
- Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature.Reumatologia clinica · 2023Article
- Review
- Does post-COVID reactive arthritis exist? Experience of a tertiary care centre with a review of the literature.Reumatologia clinica · 2023Review
- COVID-19-associated arthritis: an emerging new entity?RMD open · 2022Review
- Reactive arthritis before and after the onset of the COVID-19 pandemic.Clinical rheumatology · 2022Review
- New-onset Polymyalgia Rheumatica Following the Administration of the Pfizer-BioNTech COVID-19 Vaccine.Internal medicine (Tokyo, Japan) · 2022Article
- Successful Use of Certolizumab Pegol for Refractory Psoriatic Arthritis Triggered by COVID-19 Infection.Internal medicine (Tokyo, Japan) · 2022Article
- Reactive arthritis and silent thyroiditis following SARS-CoV-2 infection: Case report and review of the literature.Clinical case reports · 2022Article
- COVID-19-induced psoriatic arthritis: a case report.Therapeutic advances in chronic disease · 2022Article
- Magnetic resonance imaging of rheumatological diseases.Polish journal of radiology · 2022Review
- Post-COVID Reactive Arthritis.Indian journal of pediatrics · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), is a novel virus that results in a variety of clinical manifestations. In this report, I describe an uncommon presentation of reactive arthritis (ReA) following COVID-19. I report the case of a 39-year-old woman who presented with arthritis in the small joints of the hands after recovery from COVID-19 infection. To my knowledge, only four cases involving such a presentation have been reported in the literature so far.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.